Stockreport

Biopharma Can Reduce the Cost of Bringing A Treatment to Market by More Than US$1 Billion, According to Accenture Report

Accenture plc Class A Ordinary Shares (Ireland)  (ACN) 
Last accenture plc class a ordinary shares (ireland) earnings: 3/19 06:44 am Check Earnings Report
US:NYSE Investor Relations: investor.accenture.com
PDF Savings could be passed on to patients to improve affordability and access NEW YORK--(BUSINESS WIRE)--A new report from Accenture (NYSE: ACN) identifies three steps b [Read more]